Sarepta Therapeutics, Inc. (BVMF:S1RP34)
Brazil flag Brazil · Delayed Price · Currency is BRL
4.740
+0.060 (1.28%)
At close: Feb 10, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
EXONDYS 51 Revenue
--540.58M
EXONDYS 51 Revenue Growth
--5.63%
AMONDYS 45 Revenue
--273.76M
AMONDYS 45 Revenue Growth
--27.58%
VYONDYS 53 Revenue
--130.19M
VYONDYS 53 Revenue Growth
--10.86%
Total PMO Products Revenue
960.36M967.17M944.52M
Total PMO Products Revenue Growth
-0.70%2.40%11.94%
ELEVIDYS Revenue
1.17B820.79M200.36M
ELEVIDYS Revenue Growth
42.85%309.67%-
Total Products Revenue
2.13B1.79B1.14B
Total Products Revenue Growth
19.29%56.17%35.69%
Collaboration and Other Revenue
280.87M114.02M98.46M
Collaboration and Other Revenue Growth
146.33%15.80%10.33%
Revenue (Other)
-2.13B-1.79B-1.14B
Revenue (Total)
2.41B1.90B1.24B
Revenue (Total) Growth
26.91%52.97%33.26%
Updated Sep 30, 2025. Data Source: Fiscal.ai.